Weekly Vinorelbine versus Docetaxel for Metastatic Breast Cancer after Failing Anthracycline Treatment

Publisher： Karger

E-ISSN： 2296-5262|31|8-9|447-453

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.31, Iss.8-9, 2008-08, pp. : 447-453

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Clinical Phase II Study of a Non-Anthracycline Sequential Combination of Cisplatin-Vinorelbine Followed by Docetaxel as First-Line Treatment in Metastatic Breast Cancer

By  

Oncology, Vol. 70, Iss. 5, 2007-01 ,pp. : 330-338

Karger

Access to resources Recommend Favorite

Docetaxel Weekly with Metastatic Breast Cancer

By  

Oncology Research and Treatment, Vol. 30, Iss. 8-9, 2007-09 ,pp. : 407-408

Karger

Access to resources Recommend Favorite

Weekly Combination of Docetaxel and Vinorelbine in Metastatic Breast Cancer: A Phase I/II Study

By  

Oncology, Vol. 67, Iss. 3-4, 2004-11 ,pp. : 257-261

Karger

Access to resources Recommend Favorite

Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel plus Doxorubicin (D4) for First-Line Treatment of Metastatic Breast Cancer

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 204-210

Karger

Access to resources Recommend Favorite

Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer

By  

Oncology, Vol. 79, Iss. 3-4, 2011-03 ,pp. : 197-203

Karger

Access to resources Recommend Favorite